Back to Search
Start Over
New Findings from National Cancer Institute (NCI) Describe Advances in Ovarian Cancer [Poly (ADP-Ribose) Polymerase Inhibitor Olaparib-Resistant BRCA1-Mutant Ovarian Cancer Cells Demonstrate Differential Sensitivity to PARP Inhibitor Rechallenge].
- Source :
- Women's Health Weekly; 11/25/2024, p645-645, 1p
- Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 10787240
- Database :
- Supplemental Index
- Journal :
- Women's Health Weekly
- Publication Type :
- Periodical
- Accession number :
- 181022561